Publications-Theses
Article View/Open
Publication Export
-
Google ScholarTM
NCCU Library
Citation Infomation
Related Publications in TAIR
題名 以動態能力的觀點探討外商藥廠的永續管理－以A公司為例
Exploring the Sustainability Management of Multinational Pharmaceutical Companies from the Perspective of Dynamic Capabilities: A Case Study of Company A作者 林勤文
Lin, Chin-Wen貢獻者 吳豐祥
Wu, Feng-Shang
林勤文
Lin, Chin-Wen關鍵詞 動態能力
永續管理
外商藥廠
跨國企業
Dynamic Capability
Sustainability Management
Foreign Pharmaceutical Companies
Multinational Enterprises日期 2025 上傳時間 1-Jul-2025 14:32:24 (UTC+8) 摘要 隨著全球永續發展議題日益受到重視，外商藥廠面臨來自國際法規、社會 期待與產業競爭的多重壓力，促使企業須在穩健經營與永續創新間尋求動態平衡。在生技醫藥產業中，企業不僅需因應各國政府對環境、社會與治理標準的規範，亦需回應醫療專業倫理與地方社會之期待。永續管理因此成為企業長期發展策略中不可或缺的一環。 然而，永續管理不僅涉及策略規劃與資源投入，更需結合母公司與子公司 之間的協作機制，建構因應環境變遷的動態調適能力。本研究以Teece (2007; 2018a)所提出之動態能力架構為理論主軸，結合永續管理架構與跨國企業網絡觀點，探討外商藥廠子公司如何透過動態能力的建構來推動永續管理，並進一步分析子公司與總部之間如何協調資源與知識以實現永續價值。 本研究採用質性研究法，以外商藥廠子公司個案公司A為研究對象，透過 深度訪談，佐以次級資料的蒐集分析，歸納出該企業的永續管理推動過程中各構面之實務作為與內部互動邏輯。所得到的主要結論如下： 一、外商藥廠子公司在推動永續管理過程的感知上，會由被動轉為主動，並會結合母公司全球策略、利益相關者意見，以及子公司在地知識，建構雙向 資訊流動機制，以強化永續感知與策略連結。 二、外商藥廠子公司在推動永續管理過程的機會捕捉上，會結合全球統一策略框架、在地需求與組織資源，以建構動態且具滾動調整能力的永續目標與 策略捕捉能力。 三、外商藥廠子公司在推動永續管理過程的策略制度上，會透過總部資源支 持、高階主管引導推動、組織學習機制與結構調整等，來強化策略捕捉過 程中的組織吸收與學習能力，以落實策略與持續優化。 四、外商藥廠子公司在推動永續管理過程的轉換上，會透過資源再配置與內部文化建構等作法，來強化其轉換能力，並促進永續策略從規劃到執行的有 效轉化。 五、外商藥廠子公司在推動永續管理的過程中，會透過制度化的評估與回饋機制，來強化其永續管理的績效與調整，並透過經濟、社會與環境等三層面 多元價值創造，來展現出其永續導向的競爭優勢。 最後，本論文並闡述本研究在學術上的貢獻，以及實務上與後續研究上的 建議。
As global attention to sustainable development continues to grow, foreign pharmaceutical companies are facing mounting pressures from international regulations, societal expectations, and industry competition. These challenges compel enterprises to strike a dynamic balance between stable operations and sustainable innovation. In the biotechnology and pharmaceutical industry, companies must not only comply with diverse ESG standards set by various governments but also respond to medical ethics and local community expectations. Sustainability management has therefore become an essential part of long-term corporate strategy. However, effective sustainability management involves more than strategic planning and resource allocation. It also requires collaborative mechanisms between headquarters and subsidiaries to build dynamic capabilities for adapting to environmental changes. Drawing on Teece’s (2007; 2018a) dynamic capabilities framework as its theoretical foundation, this study integrates sustainability management principles and multinational enterprise network perspectives to explore how foreign pharmaceutical firms develop dynamic capabilities to implement sustainability strategies. It further examines how headquarters and subsidiaries coordinate resources and knowledge to create sustainable value. This research adopts a qualitative case study approach, using Company A as the focal case. Data were collected through in-depth interviews and secondary document analysis to identify practical actions and internal interaction logic across various stages of the sustainability management process. Key research findings include: 1. Subsidiaries of foreign pharmaceutical companies are transitioning from passive execution to proactive sensing, aligning global strategies from headquarters with local knowledge from subsidiaries, and establishing bidirectional information flow mechanisms to enhance sustainability awareness and strategic alignment. 2. Subsidiaries of foreign pharmaceutical companies integrate global strategic frameworks, local demands, organizational resources, and stakeholder perspectives to formulate flexible and adaptive sustainability goals and strategies. 3. Through headquarters resource support, leadership engagement, and organizational learning mechanisms, subsidiaries of foreign pharmaceutical companies enhance absorptive and learning capabilities during the strategy formulation phase to ensure execution and continuous optimization. 4. Structural adjustments, resource reallocation, and cultural embedding of subsidiaries of a foreign pharmaceutical companies strengthen transformation capabilities, enabling effective implementation of sustainability strategies. 5. Institutionalized evaluation and feedback mechanisms of subsidiaries of a foreign pharmaceutical companies improve sustainability performance and enable ongoing adjustments, thereby generating multi-dimensional value across economic, social, and environmental dimensions and reinforcing sustainability oriented competitive advantages. The end of the thesis presents academic contributions, practical implications, and recommendations for future research.參考文獻 Alavi, M., & Leidner, D. E. (2001). Review: Knowledge management and knowledge management systems: Conceptual foundations and research issues. MIS Quarterly, 25(1), 107–136. https://doi.org/10.2307/3250961 AstraZeneca. (2024). Sustainability report 2023. Retrieved April 1, 2025, from https://www.astrazeneca.com/content/dam/az/Sustainability/2024/pdf/Sustainability-Report-2023.pdf AstraZeneca. (2024). AZ impact publication 2024. Retrieved April 1, 2025, from https://www.astrazeneca.com/content/dam/az/Sustainability/2024/pdf/AZImpact-Publication-2024.pdf AstraZeneca. (2025). Sustainability data annex 2024. Retrieved April 1, 2025, from https://www.astrazeneca.com/content/dam/az/Sustainability/2025/pdf/Sustainability-Data-Annex-2024.pdf Barney, J. (1991). Firm resources and sustained competitive advantage. Journal of Management, 17(1), 99–120. https://doi.org/10.1177/014920639101700108 Bartlett, C. A., & Ghoshal, S. (1989). Managing across borders: The transnational solution. Boston, MA: Harvard Business School Press. Baumgartner, R. J., & Rauter, R. (2016). Strategic perspectives of corporate sustainability management to develop a sustainable organization. Journal of Cleaner Production, 140(2), 81–92. https://doi.org/10.1016/j.jclepro.2016.04.146 Bieker, T. (2003). Sustainability management with the Balanced Scorecard [Working paper]. Institute for Economy and the Environment, University of St. Gallen. Birkinshaw, J., & Hood, N. (1998). Multinational subsidiary evolution: Capability and charter change in foreign-owned subsidiary companies. Academy of Management Review, 23(4), 773–795. BlackRock. (2020). A fundamental reshaping of finance. Retrieved March 9, 2025, from https://www.blackrock.com Bowen, H. R. (1953). Social responsibilities of the businessman. Harper & Row. Chittoor, R., & Ray, S. (2007). Internationalization paths of Indian pharmaceutical firms—A strategic group analysis. Journal of International Management, 13(3), 338–355. Davenport, T. H. (1998). Working knowledge: How organizations manage what they know. Retrieved January 19, 2025, from https://doi.org/10.1145/348772.348775 DiMaggio, P. J., & Powell, W. W. (1983). The iron cage revisited: Institutional isomorphism and collective rationality in organizational fields. American Sociological Review, 48(2), 147–160. Dunlap-Hinkler, D., Mudambi, R., & Kotabe, M. (2010). A story of breakthrough versus incremental innovation: Corporate entrepreneurship in the global pharmaceutical industry. Strategic Entrepreneurship Journal, 5(2), 106–127. Dyllick, T., & Hockerts, K. (2002). Beyond the business case for corporate sustainability. Business Strategy and the Environment, 11(2), 130–141. Eisenhardt, K. M., & Martin, J. A. (2000). Dynamic capabilities: What are they? Strategic Management Journal, 21(10–11), 1105–1121. https://doi.org/10.1002/1097-0266(200010/11)21:10/11<1105::AIDSMJ133>3.0.CO;2-E Elkington, J. (1997). Cannibals with forks: The triple bottom line of 21st-century business. Capstone. European Commission. (2019). The European Green Deal. Retrieved March 10, 2025, from https://ec.europa.eu/green-deal Figge, F., Hahn, T., Schaltegger, S., & Wagner, M. (2002). The sustainability balanced scorecard – Linking sustainability management to business strategy. Business Strategy and the Environment, 11(5), 269–284. https://doi.org/10.1002/bse.339 Foss, N. J., & Pedersen, T. (2004). Organizing knowledge processes in the multinational corporation: An introduction. Journal of International Business Studies, 35(5), 340–349. Freeman, R. E. (1984). Strategic management: A stakeholder approach. Pitman. Friede, G., Busch, T., & Bassen, A. (2015). ESG and financial performance: Aggregated evidence from more than 2000 empirical studies. Journal of Sustainable Finance & Investment, 5(4), 210–233. Gassmann, O., Reepmeyer, G., & von Zedtwitz, M. (2008). Leading pharmaceutical innovation: Trends and drivers for growth in the pharmaceutical industry. Springer Science & Business Media. GlobalData. (2024). The future of pharma: Insight and analysis. Hart, S. L., & Milstein, M. B. (2003). Creating sustainable value. Academy of Management Executive, 17(2), 56–69. Helfat, C. E., & Martin, J. A. (2015). Dynamic managerial capabilities: Review and assessment of managerial impact on strategic change. Journal of Management, 41(5), 1281–1312. https://doi.org/10.1177/0149206314561301 Helfat, C. E., & Peteraf, M. A. (2018). Managerial cognitive capabilities and the microfoundations of dynamic capabilities. Strategic Management Journal, 36(6), 831–850. https://doi.org/10.1002/smj.2247 Hossain, M. U., Ng, S. T., & Antwi-Afari, M. F. (2020). A review of the sustainable building life cycle assessment research trend: Current status and future needs. Sustainability, 12(18), 7705. https://doi.org/10.3390/su12187705 Intergovernmental Panel on Climate Change (IPCC). (2018). Global warming of 1.5°C: Special report. Retrieved March 9, 2025, from https://www.ipcc.ch IQVIA Institute for Human Data Science. (2024). The global use of medicines 2024: Outlook to 2028. Manolopoulos, D., Söderquist, K. E., & Pearce, R. (2011). Coordinating decentralized research and development laboratories: A survey analysis. Journal of International Management, 17(2), 114–129. Mäkelä, K., & Brewster, C. (2009). Interunit interaction contexts, interpersonal social capital, and the differing levels of knowledge sharing. Human Resource Management, 48(4), 591–613. https://doi.org/10.1002/hrm.20300 Malerba, F., & Orsenigo, L. (2015). The evolution of the pharmaceutical industry. Business History, 57(5), 664–687. Microsoft. (2020). Microsoft will be carbon negative by 2030. Retrieved March 2, 2025, from https://blogs.microsoft.com Meyer, K. E., & Su, Y. S. (2015). Integration and responsiveness in subsidiaries in emerging economies. Journal of World Business, 50(1), 149–158. Mudambi, R., & Swift, T. (2011). Leveraging knowledge and competencies across space: The next frontier in international business. Journal of International Management, 17(3), 186–189. Nawaz, W., & Koç, M. (2018). Development of a systematic framework for sustainability management of organizations. Journal of Cleaner Production, 171, 1255–1274. https://doi.org/10.1016/j.jclepro.2017.10.011 Pisano, G. P. (2006). Science business: The promise, the reality, and the future of biotech. Harvard Business Press. Porter, M. E., & Kramer, M. R. (2011). Creating shared value. Harvard Business Review, 89(1/2), 62–77. Principles for Responsible Investment (PRI). (2006). The Principles for Responsible Investment. Retrieved March 2, 2025, from https://www.unpri.org Sala, S., Ciuffo, B., & Nijkamp, P. (2015). A systemic framework for sustainability assessment. Ecological Economics, 119, 314–325. Schweizer, L. (2005). Organizational integration of acquired biotechnology companies into pharmaceutical companies: The need for a hybrid approach. Academy of Management Journal, 48(6), 1051–1074. Searcy, C. (2009). The role of sustainable development indicators in corporate decision-making. International Journal of Sustainable Development & World Ecology, 16(2), 89–98. Retrieved March 3, 2025, from https://citeseerx.ist.psu.edu/document? repid=rep1&type=pdf&doi=14e429573f02177da59e7150bf72a663ea2a2781 Sheldon, O. (1923). The philosophy of management. Pitman. Starik, M., & Kanashiro, P. (2013). Toward a theory of sustainability management: Uncovering and integrating the nearly obvious. Organization & Environment, 26(1), 7–30. https://doi.org/10.1177/1086026612474958 Teece, D. J. (1997). Dynamic capabilities and strategic management. Strategic Management Journal, 18(7), 509–533. https://doi.org/10.1002/(SICI)10970266(199708)18:7<509::AID-SMJ882>3.0.CO;2-Z Teece, D. J. (2007). Explicating dynamic capabilities: The nature and microfoundations of (sustainable) enterprise performance. Strategic Management Journal, 28(13), 1319–1350. https://doi.org/10.1002/smj.640 Teece, D. J. (2018a). Business models and dynamic capabilities. Long Range Planning, 51(1), 40–49. https://doi.org/10.1016/j.lrp.2017.06.007 Teece, D. J. (2018b). Dynamic capabilities as (workable) management systems theory. Journal of Management & Organization, 24(3), 359–368. https://doi.org/10.1017/jmo.2017.75 Teece, D. J., Pisano, G., & Shuen, A. (1997). Dynamic capabilities and strategic management. Strategic Management Journal, 18(7), 509–533. https://doi.org/10.1002/(SICI)1097-0266(199708)18:7<509::AIDSMJ882>3.0.CO;2-Z United Nations. (2005). Kyoto Protocol to the United Nations Framework Convention on Climate Change. Retrieved March 12, 2025, from https://unfccc.int United Nations Framework Convention on Climate Change (UNFCCC). (2015). The Paris Agreement. Retrieved March 12, 2025, from https://unfccc.int United Nations Global Compact. (2004). Who cares wins. Retrieved March 12, 2025, from https://www.unglobalcompact.org United Nations World Commission on Environment and Development (UNWCED). (1987). Our common future. Oxford University Press. Wernerfelt, B. (1984). A resource-based view of the firm. Strategic Management Journal, 5(2), 171–180. https://doi.org/10.1002/smj.4250050207 White House. (2021). American clean energy plan. Retrieved March 12, 2025, from https://www.whitehouse.gov Williams, A., Kennedy, S., Philipp, F., & Whiteman, G. (2017). Systems thinking: A review of sustainability management research. Journal of Cleaner Production, 148, 866–881. https://doi.org/10.1016/j.jclepro.2017.02.002 Yin, R. K. (2018). Case study research and applications: Design and methods (6th ed.). Thousand Oaks, CA: Sage Publications. Yeung, H. W. C., & Liu, W. (2008). Globalizing China: The rise of mainland firms in the global economy. Eurasian Geography and Economics, 49(1), 57–86. Zeller, C. (2004). North Atlantic innovative relations of Swiss pharmaceuticals and the proximities with regional biotech arenas. Economic Geography, 80(1), 83-111. Zollo, M., & Winter, S. G. (2002). Deliberate learning and the evolution of dynamic capabilities. Organization Science, 13(3), 339–351. https://doi.org/10.1287/orsc.13.3.339.2780 台灣趨勢研究（2024）。《 2024 製藥與藥品製造產業報告》。上網日期：2025年 1 月25日，檢自：https://www.twtrend.com/trend-detail/manufa 沈柏延（2022）。從動態能力的觀點探討企業的數位轉型。未出版之博士論文，國立政治大學，科技管理與智慧財產研究所，台北市。 林凱晴（2024）。以核心能耐觀點探討本土與在台外商藥廠之智慧資本。未出版之碩士論文，國立政治大學，科技管理與智慧財產研究所，台北市。 生物技術醫療政策研究中心（2024）。《 2023 生醫上市櫃營收前 20 大暨各領域營收表現》。上網日期：2025年1月24日，檢自：https://ibmi.taiwan-healthcare.org/zh/news_detail.php?REFDOCID=0s731pmanz0o43x7&REFDOCTYPID=0qm3a0y0465xgddh 蘇志騰（2021）。以動態能耐觀點探討台灣鋰電池模組廠商轉型之個案研究－以S公司為例。未出版之碩士論文，國立政治大學，科技管理與智慧財產研究所，台北市。 行政院環保署（2022）。《氣候變遷因應法》。上網日期：2025年4月1日，檢自：https://www.epa.gov.tw 經濟部產業發展署（2024）。《 2024 生技產業白皮書》。台北市：中華民國經濟部。 鍾宜玲（2011）。跨國企業在台灣實行企業社會責任之探討——以醫藥產業為例。未出版之碩士論文，國立政治大學，台北市。 描述 碩士
國立政治大學
科技管理與智慧財產研究所
112364122資料來源 http://thesis.lib.nccu.edu.tw/record/#G0112364122 資料類型 thesis dc.contributor.advisor 吳豐祥 zh_TW dc.contributor.advisor Wu, Feng-Shang en_US dc.contributor.author (Authors) 林勤文 zh_TW dc.contributor.author (Authors) Lin, Chin-Wen en_US dc.creator (作者) 林勤文 zh_TW dc.creator (作者) Lin, Chin-Wen en_US dc.date (日期) 2025 en_US dc.date.accessioned 1-Jul-2025 14:32:24 (UTC+8) - dc.date.available 1-Jul-2025 14:32:24 (UTC+8) - dc.date.issued (上傳時間) 1-Jul-2025 14:32:24 (UTC+8) - dc.identifier (Other Identifiers) G0112364122 en_US dc.identifier.uri (URI) https://nccur.lib.nccu.edu.tw/handle/140.119/157721 - dc.description (描述) 碩士 zh_TW dc.description (描述) 國立政治大學 zh_TW dc.description (描述) 科技管理與智慧財產研究所 zh_TW dc.description (描述) 112364122 zh_TW dc.description.abstract (摘要) 隨著全球永續發展議題日益受到重視，外商藥廠面臨來自國際法規、社會 期待與產業競爭的多重壓力，促使企業須在穩健經營與永續創新間尋求動態平衡。在生技醫藥產業中，企業不僅需因應各國政府對環境、社會與治理標準的規範，亦需回應醫療專業倫理與地方社會之期待。永續管理因此成為企業長期發展策略中不可或缺的一環。 然而，永續管理不僅涉及策略規劃與資源投入，更需結合母公司與子公司 之間的協作機制，建構因應環境變遷的動態調適能力。本研究以Teece (2007; 2018a)所提出之動態能力架構為理論主軸，結合永續管理架構與跨國企業網絡觀點，探討外商藥廠子公司如何透過動態能力的建構來推動永續管理，並進一步分析子公司與總部之間如何協調資源與知識以實現永續價值。 本研究採用質性研究法，以外商藥廠子公司個案公司A為研究對象，透過 深度訪談，佐以次級資料的蒐集分析，歸納出該企業的永續管理推動過程中各構面之實務作為與內部互動邏輯。所得到的主要結論如下： 一、外商藥廠子公司在推動永續管理過程的感知上，會由被動轉為主動，並會結合母公司全球策略、利益相關者意見，以及子公司在地知識，建構雙向 資訊流動機制，以強化永續感知與策略連結。 二、外商藥廠子公司在推動永續管理過程的機會捕捉上，會結合全球統一策略框架、在地需求與組織資源，以建構動態且具滾動調整能力的永續目標與 策略捕捉能力。 三、外商藥廠子公司在推動永續管理過程的策略制度上，會透過總部資源支 持、高階主管引導推動、組織學習機制與結構調整等，來強化策略捕捉過 程中的組織吸收與學習能力，以落實策略與持續優化。 四、外商藥廠子公司在推動永續管理過程的轉換上，會透過資源再配置與內部文化建構等作法，來強化其轉換能力，並促進永續策略從規劃到執行的有 效轉化。 五、外商藥廠子公司在推動永續管理的過程中，會透過制度化的評估與回饋機制，來強化其永續管理的績效與調整，並透過經濟、社會與環境等三層面 多元價值創造，來展現出其永續導向的競爭優勢。 最後，本論文並闡述本研究在學術上的貢獻，以及實務上與後續研究上的 建議。 zh_TW dc.description.abstract (摘要) As global attention to sustainable development continues to grow, foreign pharmaceutical companies are facing mounting pressures from international regulations, societal expectations, and industry competition. These challenges compel enterprises to strike a dynamic balance between stable operations and sustainable innovation. In the biotechnology and pharmaceutical industry, companies must not only comply with diverse ESG standards set by various governments but also respond to medical ethics and local community expectations. Sustainability management has therefore become an essential part of long-term corporate strategy. However, effective sustainability management involves more than strategic planning and resource allocation. It also requires collaborative mechanisms between headquarters and subsidiaries to build dynamic capabilities for adapting to environmental changes. Drawing on Teece’s (2007; 2018a) dynamic capabilities framework as its theoretical foundation, this study integrates sustainability management principles and multinational enterprise network perspectives to explore how foreign pharmaceutical firms develop dynamic capabilities to implement sustainability strategies. It further examines how headquarters and subsidiaries coordinate resources and knowledge to create sustainable value. This research adopts a qualitative case study approach, using Company A as the focal case. Data were collected through in-depth interviews and secondary document analysis to identify practical actions and internal interaction logic across various stages of the sustainability management process. Key research findings include: 1. Subsidiaries of foreign pharmaceutical companies are transitioning from passive execution to proactive sensing, aligning global strategies from headquarters with local knowledge from subsidiaries, and establishing bidirectional information flow mechanisms to enhance sustainability awareness and strategic alignment. 2. Subsidiaries of foreign pharmaceutical companies integrate global strategic frameworks, local demands, organizational resources, and stakeholder perspectives to formulate flexible and adaptive sustainability goals and strategies. 3. Through headquarters resource support, leadership engagement, and organizational learning mechanisms, subsidiaries of foreign pharmaceutical companies enhance absorptive and learning capabilities during the strategy formulation phase to ensure execution and continuous optimization. 4. Structural adjustments, resource reallocation, and cultural embedding of subsidiaries of a foreign pharmaceutical companies strengthen transformation capabilities, enabling effective implementation of sustainability strategies. 5. Institutionalized evaluation and feedback mechanisms of subsidiaries of a foreign pharmaceutical companies improve sustainability performance and enable ongoing adjustments, thereby generating multi-dimensional value across economic, social, and environmental dimensions and reinforcing sustainability oriented competitive advantages. The end of the thesis presents academic contributions, practical implications, and recommendations for future research. en_US dc.description.tableofcontents 第一章 緒論 1 第一節 研究背景與動機 1 第二節 研究目的與問題 3 第三節 論文結構 5 第二章 文獻回顧 6 第一節 生技醫藥產業 6 第二節 動態能力 24 第三節 永續管理 32 第四節 文獻回顧小結與缺口 40 第三章 研究方法 44 第一節 觀念性架構 44 第二節 研究變項說明 45 第三節 研究設計 48 第四章 個案研究 52 第一節 個案公司簡介 52 第二節 個案公司對永續管理的感知 54 第三節 個案公司對永續管理的捕捉 59 第四節 個案公司對永續管理的轉換 66 第五節 個案公司永續管理的結果 69 第六節 個案小結 73 第五章 研究發現與討論 75 第一節 永續管理的感知方面 75 第二節 永續管理的捕捉方面 79 第三節 永續管理的轉換方面 86 第四節 永續管理的結果方面 90 第六章 研究結論與建議 93 第一節 研究結論 93 第二節 理論貢獻與意涵 98 第三節 實務建議 100 第四節 後續研究建議 103 參考文獻 105 附錄 115 zh_TW dc.format.extent 6537805 bytes - dc.format.mimetype application/pdf - dc.source.uri (資料來源) http://thesis.lib.nccu.edu.tw/record/#G0112364122 en_US dc.subject (關鍵詞) 動態能力 zh_TW dc.subject (關鍵詞) 永續管理 zh_TW dc.subject (關鍵詞) 外商藥廠 zh_TW dc.subject (關鍵詞) 跨國企業 zh_TW dc.subject (關鍵詞) Dynamic Capability en_US dc.subject (關鍵詞) Sustainability Management en_US dc.subject (關鍵詞) Foreign Pharmaceutical Companies en_US dc.subject (關鍵詞) Multinational Enterprises en_US dc.title (題名) 以動態能力的觀點探討外商藥廠的永續管理－以A公司為例 zh_TW dc.title (題名) Exploring the Sustainability Management of Multinational Pharmaceutical Companies from the Perspective of Dynamic Capabilities: A Case Study of Company A en_US dc.type (資料類型) thesis en_US dc.relation.reference (參考文獻) Alavi, M., & Leidner, D. E. (2001). Review: Knowledge management and knowledge management systems: Conceptual foundations and research issues. MIS Quarterly, 25(1), 107–136. https://doi.org/10.2307/3250961 AstraZeneca. (2024). Sustainability report 2023. Retrieved April 1, 2025, from https://www.astrazeneca.com/content/dam/az/Sustainability/2024/pdf/Sustainability-Report-2023.pdf AstraZeneca. (2024). AZ impact publication 2024. Retrieved April 1, 2025, from https://www.astrazeneca.com/content/dam/az/Sustainability/2024/pdf/AZImpact-Publication-2024.pdf AstraZeneca. (2025). Sustainability data annex 2024. Retrieved April 1, 2025, from https://www.astrazeneca.com/content/dam/az/Sustainability/2025/pdf/Sustainability-Data-Annex-2024.pdf Barney, J. (1991). Firm resources and sustained competitive advantage. Journal of Management, 17(1), 99–120. https://doi.org/10.1177/014920639101700108 Bartlett, C. A., & Ghoshal, S. (1989). Managing across borders: The transnational solution. Boston, MA: Harvard Business School Press. Baumgartner, R. J., & Rauter, R. (2016). Strategic perspectives of corporate sustainability management to develop a sustainable organization. Journal of Cleaner Production, 140(2), 81–92. https://doi.org/10.1016/j.jclepro.2016.04.146 Bieker, T. (2003). Sustainability management with the Balanced Scorecard [Working paper]. Institute for Economy and the Environment, University of St. Gallen. Birkinshaw, J., & Hood, N. (1998). Multinational subsidiary evolution: Capability and charter change in foreign-owned subsidiary companies. Academy of Management Review, 23(4), 773–795. BlackRock. (2020). A fundamental reshaping of finance. Retrieved March 9, 2025, from https://www.blackrock.com Bowen, H. R. (1953). Social responsibilities of the businessman. Harper & Row. Chittoor, R., & Ray, S. (2007). Internationalization paths of Indian pharmaceutical firms—A strategic group analysis. Journal of International Management, 13(3), 338–355. Davenport, T. H. (1998). Working knowledge: How organizations manage what they know. Retrieved January 19, 2025, from https://doi.org/10.1145/348772.348775 DiMaggio, P. J., & Powell, W. W. (1983). The iron cage revisited: Institutional isomorphism and collective rationality in organizational fields. American Sociological Review, 48(2), 147–160. Dunlap-Hinkler, D., Mudambi, R., & Kotabe, M. (2010). A story of breakthrough versus incremental innovation: Corporate entrepreneurship in the global pharmaceutical industry. Strategic Entrepreneurship Journal, 5(2), 106–127. Dyllick, T., & Hockerts, K. (2002). Beyond the business case for corporate sustainability. Business Strategy and the Environment, 11(2), 130–141. Eisenhardt, K. M., & Martin, J. A. (2000). Dynamic capabilities: What are they? Strategic Management Journal, 21(10–11), 1105–1121. https://doi.org/10.1002/1097-0266(200010/11)21:10/11<1105::AIDSMJ133>3.0.CO;2-E Elkington, J. (1997). Cannibals with forks: The triple bottom line of 21st-century business. Capstone. European Commission. (2019). The European Green Deal. Retrieved March 10, 2025, from https://ec.europa.eu/green-deal Figge, F., Hahn, T., Schaltegger, S., & Wagner, M. (2002). The sustainability balanced scorecard – Linking sustainability management to business strategy. Business Strategy and the Environment, 11(5), 269–284. https://doi.org/10.1002/bse.339 Foss, N. J., & Pedersen, T. (2004). Organizing knowledge processes in the multinational corporation: An introduction. Journal of International Business Studies, 35(5), 340–349. Freeman, R. E. (1984). Strategic management: A stakeholder approach. Pitman. Friede, G., Busch, T., & Bassen, A. (2015). ESG and financial performance: Aggregated evidence from more than 2000 empirical studies. Journal of Sustainable Finance & Investment, 5(4), 210–233. Gassmann, O., Reepmeyer, G., & von Zedtwitz, M. (2008). Leading pharmaceutical innovation: Trends and drivers for growth in the pharmaceutical industry. Springer Science & Business Media. GlobalData. (2024). The future of pharma: Insight and analysis. Hart, S. L., & Milstein, M. B. (2003). Creating sustainable value. Academy of Management Executive, 17(2), 56–69. Helfat, C. E., & Martin, J. A. (2015). Dynamic managerial capabilities: Review and assessment of managerial impact on strategic change. Journal of Management, 41(5), 1281–1312. https://doi.org/10.1177/0149206314561301 Helfat, C. E., & Peteraf, M. A. (2018). Managerial cognitive capabilities and the microfoundations of dynamic capabilities. Strategic Management Journal, 36(6), 831–850. https://doi.org/10.1002/smj.2247 Hossain, M. U., Ng, S. T., & Antwi-Afari, M. F. (2020). A review of the sustainable building life cycle assessment research trend: Current status and future needs. Sustainability, 12(18), 7705. https://doi.org/10.3390/su12187705 Intergovernmental Panel on Climate Change (IPCC). (2018). Global warming of 1.5°C: Special report. Retrieved March 9, 2025, from https://www.ipcc.ch IQVIA Institute for Human Data Science. (2024). The global use of medicines 2024: Outlook to 2028. Manolopoulos, D., Söderquist, K. E., & Pearce, R. (2011). Coordinating decentralized research and development laboratories: A survey analysis. Journal of International Management, 17(2), 114–129. Mäkelä, K., & Brewster, C. (2009). Interunit interaction contexts, interpersonal social capital, and the differing levels of knowledge sharing. Human Resource Management, 48(4), 591–613. https://doi.org/10.1002/hrm.20300 Malerba, F., & Orsenigo, L. (2015). The evolution of the pharmaceutical industry. Business History, 57(5), 664–687. Microsoft. (2020). Microsoft will be carbon negative by 2030. Retrieved March 2, 2025, from https://blogs.microsoft.com Meyer, K. E., & Su, Y. S. (2015). Integration and responsiveness in subsidiaries in emerging economies. Journal of World Business, 50(1), 149–158. Mudambi, R., & Swift, T. (2011). Leveraging knowledge and competencies across space: The next frontier in international business. Journal of International Management, 17(3), 186–189. Nawaz, W., & Koç, M. (2018). Development of a systematic framework for sustainability management of organizations. Journal of Cleaner Production, 171, 1255–1274. https://doi.org/10.1016/j.jclepro.2017.10.011 Pisano, G. P. (2006). Science business: The promise, the reality, and the future of biotech. Harvard Business Press. Porter, M. E., & Kramer, M. R. (2011). Creating shared value. Harvard Business Review, 89(1/2), 62–77. Principles for Responsible Investment (PRI). (2006). The Principles for Responsible Investment. Retrieved March 2, 2025, from https://www.unpri.org Sala, S., Ciuffo, B., & Nijkamp, P. (2015). A systemic framework for sustainability assessment. Ecological Economics, 119, 314–325. Schweizer, L. (2005). Organizational integration of acquired biotechnology companies into pharmaceutical companies: The need for a hybrid approach. Academy of Management Journal, 48(6), 1051–1074. Searcy, C. (2009). The role of sustainable development indicators in corporate decision-making. International Journal of Sustainable Development & World Ecology, 16(2), 89–98. Retrieved March 3, 2025, from https://citeseerx.ist.psu.edu/document? repid=rep1&type=pdf&doi=14e429573f02177da59e7150bf72a663ea2a2781 Sheldon, O. (1923). The philosophy of management. Pitman. Starik, M., & Kanashiro, P. (2013). Toward a theory of sustainability management: Uncovering and integrating the nearly obvious. Organization & Environment, 26(1), 7–30. https://doi.org/10.1177/1086026612474958 Teece, D. J. (1997). Dynamic capabilities and strategic management. Strategic Management Journal, 18(7), 509–533. https://doi.org/10.1002/(SICI)10970266(199708)18:7<509::AID-SMJ882>3.0.CO;2-Z Teece, D. J. (2007). Explicating dynamic capabilities: The nature and microfoundations of (sustainable) enterprise performance. Strategic Management Journal, 28(13), 1319–1350. https://doi.org/10.1002/smj.640 Teece, D. J. (2018a). Business models and dynamic capabilities. Long Range Planning, 51(1), 40–49. https://doi.org/10.1016/j.lrp.2017.06.007 Teece, D. J. (2018b). Dynamic capabilities as (workable) management systems theory. Journal of Management & Organization, 24(3), 359–368. https://doi.org/10.1017/jmo.2017.75 Teece, D. J., Pisano, G., & Shuen, A. (1997). Dynamic capabilities and strategic management. Strategic Management Journal, 18(7), 509–533. https://doi.org/10.1002/(SICI)1097-0266(199708)18:7<509::AIDSMJ882>3.0.CO;2-Z United Nations. (2005). Kyoto Protocol to the United Nations Framework Convention on Climate Change. Retrieved March 12, 2025, from https://unfccc.int United Nations Framework Convention on Climate Change (UNFCCC). (2015). The Paris Agreement. Retrieved March 12, 2025, from https://unfccc.int United Nations Global Compact. (2004). Who cares wins. Retrieved March 12, 2025, from https://www.unglobalcompact.org United Nations World Commission on Environment and Development (UNWCED). (1987). Our common future. Oxford University Press. Wernerfelt, B. (1984). A resource-based view of the firm. Strategic Management Journal, 5(2), 171–180. https://doi.org/10.1002/smj.4250050207 White House. (2021). American clean energy plan. Retrieved March 12, 2025, from https://www.whitehouse.gov Williams, A., Kennedy, S., Philipp, F., & Whiteman, G. (2017). Systems thinking: A review of sustainability management research. Journal of Cleaner Production, 148, 866–881. https://doi.org/10.1016/j.jclepro.2017.02.002 Yin, R. K. (2018). Case study research and applications: Design and methods (6th ed.). Thousand Oaks, CA: Sage Publications. Yeung, H. W. C., & Liu, W. (2008). Globalizing China: The rise of mainland firms in the global economy. Eurasian Geography and Economics, 49(1), 57–86. Zeller, C. (2004). North Atlantic innovative relations of Swiss pharmaceuticals and the proximities with regional biotech arenas. Economic Geography, 80(1), 83-111. Zollo, M., & Winter, S. G. (2002). Deliberate learning and the evolution of dynamic capabilities. Organization Science, 13(3), 339–351. https://doi.org/10.1287/orsc.13.3.339.2780 台灣趨勢研究（2024）。《 2024 製藥與藥品製造產業報告》。上網日期：2025年 1 月25日，檢自：https://www.twtrend.com/trend-detail/manufa 沈柏延（2022）。從動態能力的觀點探討企業的數位轉型。未出版之博士論文，國立政治大學，科技管理與智慧財產研究所，台北市。 林凱晴（2024）。以核心能耐觀點探討本土與在台外商藥廠之智慧資本。未出版之碩士論文，國立政治大學，科技管理與智慧財產研究所，台北市。 生物技術醫療政策研究中心（2024）。《 2023 生醫上市櫃營收前 20 大暨各領域營收表現》。上網日期：2025年1月24日，檢自：https://ibmi.taiwan-healthcare.org/zh/news_detail.php?REFDOCID=0s731pmanz0o43x7&REFDOCTYPID=0qm3a0y0465xgddh 蘇志騰（2021）。以動態能耐觀點探討台灣鋰電池模組廠商轉型之個案研究－以S公司為例。未出版之碩士論文，國立政治大學，科技管理與智慧財產研究所，台北市。 行政院環保署（2022）。《氣候變遷因應法》。上網日期：2025年4月1日，檢自：https://www.epa.gov.tw 經濟部產業發展署（2024）。《 2024 生技產業白皮書》。台北市：中華民國經濟部。 鍾宜玲（2011）。跨國企業在台灣實行企業社會責任之探討——以醫藥產業為例。未出版之碩士論文，國立政治大學，台北市。 zh_TW
